RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks
Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced the next generation of its ISSCA division's Online Academy, adding ten new curriculum tracks covering biologics, exosomes, mesenchymal stromal/stem cells (MSCs), Natural Killer cells, dendritic cells, immunotherapy, CAR-T cell science, peptide...
Read more








